Matti Anniko Selected Research

Matti Anniko Research Topics

Disease

11	Ototoxicity 07/2009 - 01/2002
8	Neoplasms (Cancer) 09/2014 - 10/2002
6	Ganglion Cysts (Ganglion) 11/2019 - 02/2010
6	Hearing Loss (Hearing Impairment) 01/2016 - 10/2005
6	Squamous Cell Carcinoma of Head and Neck 09/2014 - 11/2004
3	Meniere Disease (Menieres Disease) 10/2014 - 08/2003
3	Endolymphatic Hydrops 10/2014 - 11/2007
2	Neoplasm Metastasis (Metastasis) 07/2011 - 11/2004
2	Edema (Dropsy) 03/2009 - 11/2007
1	Carcinoma (Carcinomatosis) 03/2018
1	Lymphatic Metastasis 07/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2011
1	Wounds and Injuries (Trauma) 11/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2010
1	Disease Progression 04/2010
1	Sensorineural Hearing Loss 10/2005
1	High-Frequency Hearing Loss 10/2005
1	Residual Neoplasm 11/2004
1	Inflammation (Inflammations) 03/2003
1	Labyrinth Diseases 03/2003

Drug/Important Bio-Agent (IBA)

6	Gentamicins (Gentamicin)FDA LinkGeneric 07/2009 - 01/2002
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013 - 01/2002
4	Monoclonal AntibodiesIBA 01/2010 - 11/2004
4	AminoglycosidesIBA 01/2009 - 03/2002
3	Radioisotopes (Radionuclides)IBA 04/2010 - 06/2007
3	EdaravoneIBA 01/2009 - 01/2006
3	Pseudomonas aeruginosa Exotoxin AIBA 01/2006 - 01/2003
2	Vasopressins (Vasopressin)IBA 10/2014 - 08/2012
2	Aquaporins (Water Channels)IBA 08/2013 - 08/2012
2	DABIIBA 01/2010 - 11/2004
2	(124)I-cMAb U36IBA 01/2010 - 01/2008
2	dodecaborateIBA 01/2010 - 11/2004
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2009 - 08/2003
2	rebamipideIBA 01/2009 - 08/2003
2	Free Radical ScavengersIBA 11/2007 - 01/2006
2	calpain inhibitorsIBA 05/2003 - 01/2003
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2003 - 01/2002
1	MelatoninIBA 11/2019
1	Adenosine Triphosphatases (ATPase)IBA 05/2017
1	Histamine Receptors (Histamine Receptor)IBA 06/2016
1	Sirtuin 1IBA 01/2016
1	Latanoprost (Xalatan)FDA Link 10/2014
1	ProstaglandinsIBA 10/2014
1	Biomarkers (Surrogate Marker)IBA 09/2014
1	MicroRNAs (MicroRNA)IBA 09/2014
1	ExotoxinsIBA 01/2013
1	EndopeptidasesIBA 07/2011
1	Matrix Metalloproteinases (MMPs)IBA 07/2011
1	ZincIBA 07/2011
1	Cetuximab (Erbitux)FDA Link 01/2011
1	ADM 10IBA 11/2010
1	Epidermal Growth Factor (EGF)IBA 04/2010
1	ErbB Receptors (EGF Receptor)IBA 04/2010
1	Estrogen Receptor alphaIBA 02/2010
1	AntibodiesIBA 01/2010
1	CD44v6 antigenIBA 01/2010
1	Epinephrine (Adrenaline)FDA LinkGeneric 03/2009
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2009
1	A 7 (A-7)IBA 01/2009
1	Thioctic Acid (Lipoic Acid)IBA 01/2009
1	LipopolysaccharidesIBA 03/2008
1	AldosteroneIBA 03/2008
1	Immunoconjugates (Immunoconjugate)IBA 01/2008
1	Therapeutic UsesIBA 06/2007
1	Astatine-211IBA 06/2007
1	AntigensIBA 01/2007
1	Complement System Proteins (Complement)IBA 01/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2005
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 10/2005
1	arginine methyl esterIBA 10/2005
1	geranylgeranylacetone (teprenone)IBA 01/2005
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2005
1	4-Iodobenzoic acidIBA 11/2004
1	IsotopesIBA 11/2004
1	benzyl isothiocyanateIBA 11/2004
1	Glutathione (Reduced Glutathione)IBA 08/2003
1	CalpainIBA 05/2003
1	Caspase InhibitorsIBA 05/2003
1	CaspasesIBA 05/2003
1	GlucocorticoidsIBA 03/2003
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2003
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2003
1	Nerve Growth Factors (Neurotrophins)IBA 01/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2003

Therapy/Procedure

5	Therapeutics 01/2009 - 10/2002
2	Radioimmunotherapy 01/2011 - 06/2007
1	Radiotherapy 03/2018
1	Induction Chemotherapy 03/2018
1	Chemoradiotherapy 03/2018
1	Tracheotomy 08/2010
1	Intravenous Injections 01/2008